Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lynnette Luksch

Physician Assistant Buffalo, NY Physician Assistant

NPI 1699710939 CMS profile 76714

462 Grider St, Erie County Medical Center, Buffalo, NY 14215

Open in the dashboard

General payments

$5,299

158 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lynnette Luksch of Buffalo, NY is reported in the CMS Open Payments database as having received $5,299 across 158 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $627 15
2024 General $604 11
2023 General $1,454 57
2022 General $1,313 41
2021 General $1,302 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lynnette Luksch
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Lynnette Luksch were reported at $627. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Lynnette Luksch Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,302 $132 $37–$438 $132
2022 $1,313 $155 $48–$522 $149
2023 $1,454 $167 $52–$557 $160
2024 $604 $178 $55–$600 $164
2025 $627 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Pharmaceuticals, Inc $863 31 payments
  2. Edwards Lifesciences Corporation $618 8 payments
  3. E.R. Squibb & Sons, L.L.C. $541 14 payments
  4. Pfizer Inc. $466 11 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $441 12 payments
  6. AstraZeneca Pharmaceuticals LP $392 11 payments
  7. iRhythm Technologies, Inc. $338 9 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $309 8 payments
  9. Merck Sharp & Dohme Corporation $212 10 payments
  10. Novartis Pharmaceuticals Corporation $206 13 payments
  11. Other $914 31 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,299 158 payments
Products named General payments · program years 2021–2025
  1. XARELTO $863 31 payments
  2. LifeVest $441 12 payments
  3. FARXIGA $377 10 payments
  4. VYNDAQEL $373 9 payments
  5. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $371 5 payments
  6. ELIQUIS $262 10 payments
  7. ZIO XT Patch $254 6 payments
  8. CAMZYOS $248 2 payments
  9. JARDIANCE $228 5 payments
  10. VERQUVO $212 10 payments
  11. Other $2,077 79 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

564

Median for Physician Assistant: 241

Drug cost

$133,008

Median for Physician Assistant: $4,110

Branded share of claims

29.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 40 $41,315
Xarelto Rivaroxaban Brand 18 $26,216
Entresto Sacubitril/Valsartan Brand 24 $24,005
Farxiga Dapagliflozin Propanediol Brand 27 $22,433
Eliquis Apixaban Brand 12 $12,992
Metoprolol Succinate Generic 115 $1,729
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 15 $1,180
Bumetanide Generic 23 $645
Atorvastatin Calcium Generic 46 $483
Carvedilol Generic 48 $408

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$4,280

Medicare's payments for the services billed

Medicare patients

55

Average age 69

Services billed

70

21 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Heart failure 53%
Ischemic heart disease 53%
Diabetes 49%
Depression 47%
Atrial fibrillation 44%
Chronic kidney disease 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Arcalyst
  • Kiniksa Pharmaceuticals International, plc $150
$150 — —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $123
$123 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $28
$28 40 —
Repatha
  • Amgen Inc. $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record